Court Denies UK Agency's Appeal In Price-Fixing Spat

Law360, New York (December 4, 2008, 12:00 AM EST) -- Several pharmaceutical companies have prevailed in a long-running battle against a U.K. government agency after an appeals court rejected the office's bid to amend an indictment accusing the firms and their executives of price-fixing.

The U.K. Court of Appeals on Wednesday declined to give the Serious Fraud Office leave to appeal a lower court decision that denied its request to amend the indictment. The ruling put an end to a six-year case in which Ranbaxy (U.K.) Ltd., Goldshield Group PLC and other drug companies were charged...
To view the full article, register now.